SELECT id, `name`, primary_key, `key`, treemapgroup, name_cn, zacks_table_name, compare_key, compare_display_name from gurufocu_main.financial_definition where termpagedisplay=1 and `key` = 'CashPayments' BVNRY (Bavarian Nordic A/S) Cash Payments
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OTCPK:BVNRY) » Definitions » Cash Payments

Bavarian Nordic A/S (Bavarian Nordic A/S) Cash Payments


View and export this data going back to 2013. Start your Free Trial

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.

Bavarian Nordic A/S (Bavarian Nordic A/S) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OTCPK:BVNRY) » Definitions » Cash Payments
Comparable Companies
OCSE:GUBRA OCSE:PEG OCSE:ALK B OCSE:ZEAL OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX OCSE:GMAB ALNY BGNE BMRN SZSE:300122 RPRX
Traded in Other Exchanges
BVNKF:USA BAVAc:UK 0DPB:UK BAVA:Denmark BV3:Germany
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Website
https://www.bavarian-nordic.com
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.